Azelis Group N.V.
AZLGF
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.33B
Close$
$34.84
154.3% upside
Current Fair Value
154.3% upsideUndervalued by 154.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.33 Billion |
|---|---|
| Enterprise Value | $4.93 Billion |
| Dividend Yield | $0.26 (1.79%) |
| Earnings per Share | $0.46 |
| Beta | 0.5 |
| Outstanding Shares | 243,467,000 |
Return
| Return on Equity | 9.97% |
|---|---|
| Return on Assets | 4.94% |
| Return on Invested Capital | 12.95% |
Valuation & Multiples
| P/E Ratio | 26.89 |
|---|---|
| PEG | 1517.62 |
| Price to Sales | 0.4 |
| Price to Book Ratio | 1.25 |
| Enterprise Value to Revenue | 0.59 |
| Enterprise Value to EBIT | 7.88 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.65 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$0.60
Average shareholder expectationRevenue Estimate
$2.38 B
Average shareholder expectationNext Earnings Call
Expected Date
February 18, 2027
EPS Estimate
$0.45
Average shareholder expectationRevenue Estimate
$2.34 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Azelis Group N.V.
4,000 employees
CEO: Anna Bertona Azelis Group NV functions as a global distributor, supplying specialized chemicals and food ingredients. The company's operations extend across a diverse range of life science sectors, including personal care, pharmaceuticals, food and w...